Account
Hero background pattern

From launching your product to training your team

Remap Consulting is the pricing and market access launch partner to help you launch with confidence.

Launch Implementation

Develop and implement a pricing and market access launch strategy for your product

Learn more

Price Optimization

Having the right pharma pricing strategy is essential for your product to optimize revenues.

Learn more

Price & Market Access Training

We aim to make the transfer of knowledge more flexible, effective, and engaging.

Learn more

We work with people who’re asking:

Optimal price
What is the optimal price for our product?
Right evidence
Do we have the right evidence to support price and access to launch?
Training people
Do we have the right capabilities to train people on market access?
Market access potential
What is the pricing and market access potential for BD opportunities?

Discover the latest insights

Europe
EU releases draft act on Joint Clinical Assessment…
Consultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp…
Read more
Nordics
Nordic Pharmaceutical Forum develops new website t…
New website provides regular updates on NLF’s work, addresses challenges, and showcases collaboratio…
Read more
World EPA Congress 2024
The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar…
Read more
Italy Icon
AIFA regulatory overhaul marks milestone in Pharma
AIFA’s restructuring in Italy aims to streamline drug approval, replacing committees and introducing…
Read more
What are the 5 Pricing & Market Access trends…
Our experts provide an overview of the five key trends that could shape the pricing and market acces…
Read more
Reflecting on the Pricing & Market Access tre…
Back in January this year, we summarised the key trends our market access experts believed would dom…
Read more
ISPOR Europe 2023
We’re thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We’ll…
Read more
World Orphan Drug Congress Europe 2023 REPORT
We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
NICE’s Proportionate Approach to Technology …
Webinar: Our experts discuss NICE’s proportionate approach to technology appraisals and the implicat…
Read more
ISPOR Europe 2023: Can Just Three PICOs be Feasibl…
This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment…
Read more